Trials / Sponsors / Axon Neuroscience SE
Axon Neuroscience SE
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | A 24-month Phase 1 Pilot Study of AADvac1 in Patients With Non Fluent Primary Progressive Aphasia Primary Progressive Nonfluent Aphasia | Phase 1 | 2017-07-31 |
| Completed | 24 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's Disease Alzheimer's Disease | Phase 2 | 2016-03-01 |
| Completed | 18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease Alzheimer's Disease | Phase 1 | 2014-01-01 |
| Completed | Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease Alzheimer Disease | Phase 1 | 2013-05-01 |